Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Inder Verma

    TitleAdjunct Professor
    SchoolUniversity of California, San Diego
    DepartmentMolecular Biology
    Address9500 Gilman Drive #0932
    CA La Jolla 92093
    Phone858-453-4100
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Ramaswamy S, Tonnu N, Tachikawa K, Limphong P, Vega JB, Karmali PP, Chivukula P, Verma I. Systemic delivery of factor IX messenger RNA for protein replacement therapy. Proc Natl Acad Sci U S A. 2017 Mar 07; 114(10):E1941-E1950. PMID: 28202722.
        View in: PubMed
      2. Polley S, Passos DO, Huang DB, Mulero MC, Mazumder A, Biswas T, Verma I, Lyumkis D, Ghosh G. Structural Basis for the Activation of IKK1/a. Cell Rep. 2016 Nov 15; 17(8):1907-1914. PMID: 27851956.
        View in: PubMed
      3. Naldini L, Trono D, Verma I. Lentiviral vectors, two decades later. Science. 2016 Sep 09; 353(6304):1101-2. PMID: 27609877.
        View in: PubMed
      4. Sancho-Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, Ma L, Morey R, Krause MN, Zembrzycki A, Ansorge O, Vazquez-Ferrer E, Dubova I, Reddy P, Lam D, Hishida Y, Wu MZ, Esteban CR, O'Leary D, Wahl GM, Verma I, Laurent LC, Izpisua Belmonte JC. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat Commun. 2016 Feb 22; 7:10743. PMID: 26899176; PMCID: PMC4764898.
      5. Hirbe AC, Dahiya S, Friedmann-Morvinski D, Verma I, Clapp DW, Gutmann DH. Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation. Oncotarget. 2016 Feb 16; 7(7):7403-14. PMID: 26859681; PMCID: PMC4884927.
      6. Friedmann-Morvinski D, Narasimamurthy R, Xia Y, Myskiw C, Soda Y, Verma I. Targeting NF-?B in glioblastoma: A therapeutic approach. Sci Adv. 2016 Jan; 2(1):e1501292. PMID: 26824076; PMCID: PMC4730860.
      7. Hurtado de Mendoza T, Liu F, Verma I. Antiapoptotic Role for Lifeguard in T Cell Mediated Immune Response. PLoS One. 2015; 10(11):e0142161. PMID: 26565411; PMCID: PMC4643990.
      8. Yeddula N, Xia Y, Ke E, Beumer J, Verma I. Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma. Proc Natl Acad Sci U S A. 2015 Nov 24; 112(47):E6476-85. PMID: 26542681; PMCID: PMC4664320.
      9. Firth AL, Menon T, Parker GS, Qualls SJ, Lewis BM, Ke E, Dargitz CT, Wright R, Khanna A, Gage FH, Verma I. Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs. Cell Rep. 2015 Sep 01; 12(9):1385-90. PMID: 26299960; PMCID: PMC4559351.
      10. Font-Burgada J, Shalapour S, Ramaswamy S, Hsueh B, Rossell D, Umemura A, Taniguchi K, Nakagawa H, Valasek MA, Ye L, Kopp JL, Sander M, Carter H, Deisseroth K, Verma I, Karin M. Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer. Cell. 2015 Aug 13; 162(4):766-79. PMID: 26276631; PMCID: PMC4545590.
      11. Friedmann-Morvinski D, Bhargava V, Gupta S, Verma I, Subramaniam S. Identification of therapeutic targets for glioblastoma by network analysis. Oncogene. 2016 Feb 04; 35(5):608-20. PMID: 25961929; PMCID: PMC4641815.
      12. Wickersham IR, Sullivan HA, Pao GM, Hamanaka H, Goosens KA, Verma I, Seung HS. Lentiviral vectors for retrograde delivery of recombinases and transactivators. Cold Spring Harb Protoc. 2015 Apr 01; 2015(4):368-74. PMID: 25834255.
        View in: PubMed
      13. Xia Y, Yeddula N, Leblanc M, Ke E, Zhang Y, Oldfield E, Shaw RJ, Verma I. Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model. Nat Cell Biol. 2015 Apr; 17(4):532. PMID: 25812528.
        View in: PubMed
      14. Menon T, Firth AL, Scripture-Adams DD, Galic Z, Qualls SJ, Gilmore WB, Ke E, Singer O, Anderson LS, Bornzin AR, Alexander IE, Zack JA, Verma I. Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs. Cell Stem Cell. 2015 Apr 02; 16(4):367-72. PMID: 25772073; PMCID: PMC4545662.
      15. Xia Y, Liu YL, Xie Y, Zhu W, Guerra F, Shen S, Yeddula N, Fischer W, Low W, Zhou X, Zhang Y, Oldfield E, Verma I. A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin. Sci Transl Med. 2014 Nov 19; 6(263):263ra161. PMID: 25411474; PMCID: PMC4326221.
      16. Xia Y, Shen S, Verma I. NF-?B, an active player in human cancers. Cancer Immunol Res. 2014 Sep; 2(9):823-30. PMID: 25187272; PMCID: PMC4155602.
      17. Lee HS, Ghetti A, Pinto-Duarte A, Wang X, Dziewczapolski G, Galimi F, Huitron-Resendiz S, Piña-Crespo JC, Roberts AJ, Verma I, Sejnowski TJ, Heinemann SF. Astrocytes contribute to gamma oscillations and recognition memory. Proc Natl Acad Sci U S A. 2014 Aug 12; 111(32):E3343-52. PMID: 25071179; PMCID: PMC4136580.
      18. Firth AL, Dargitz CT, Qualls SJ, Menon T, Wright R, Singer O, Gage FH, Khanna A, Verma I. Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2014 Apr 29; 111(17):E1723-30. PMID: 24706852; PMCID: PMC4035971.
      19. Pao GM, Zhu Q, Perez-Garcia CG, Chou SJ, Suh H, Gage FH, O'Leary DD, Verma I. Role of BRCA1 in brain development. Proc Natl Acad Sci U S A. 2014 Apr 01; 111(13):E1240-8. PMID: 24639535; PMCID: PMC3977248.
      20. Friedmann-Morvinski D, Verma I. Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep. 2014 Mar; 15(3):244-53. PMID: 24531722; PMCID: PMC3989690.
      21. Hu YS, Zhu Q, Elkins K, Tse K, Li Y, Fitzpatrick JA, Verma I, Cang H. Light-sheet Bayesian microscopy enables deep-cell super-resolution imaging of heterochromatin in live human embryonic stem cells. Opt Nanoscopy. 2013; 2(1). PMID: 27795878.
        View in: PubMed
      22. Verma I. Medicine. Gene therapy that works. Science. 2013 Aug 23; 341(6148):853-5. PMID: 23970689.
        View in: PubMed
      23. Polley S, Huang DB, Hauenstein AV, Fusco AJ, Zhong X, Vu D, Schröfelbauer B, Kim Y, Hoffmann A, Verma I, Ghosh G, Huxford T. A structural basis for I?B kinase 2 activation via oligomerization-dependent trans auto-phosphorylation. PLoS Biol. 2013; 11(6):e1001581. PMID: 23776406; PMCID: PMC3678999.
      24. Soda Y, Myskiw C, Rommel A, Verma I. Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme. J Mol Med (Berl). 2013 Apr; 91(4):439-48. PMID: 23512266; PMCID: PMC3665343.
      25. Holland AJ, Fachinetti D, Zhu Q, Bauer M, Verma I, Nigg EA, Cleveland DW. The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle. Genes Dev. 2012 Dec 15; 26(24):2684-9. PMID: 23249732; PMCID: PMC3533073.
      26. Yang W, Xia Y, Cao Y, Zheng Y, Bu W, Zhang L, You MJ, Koh MY, Cote G, Aldape K, Li Y, Verma I, Chiao PJ, Lu Z. EGFR-induced and PKCe monoubiquitylation-dependent NF-?B activation upregulates PKM2 expression and promotes tumorigenesis. Mol Cell. 2012 Dec 14; 48(5):771-84. PMID: 23123196; PMCID: PMC3526114.
      27. Friedmann-Morvinski D, Bushong EA, Ke E, Soda Y, Marumoto T, Singer O, Ellisman MH, Verma I. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science. 2012 Nov 23; 338(6110):1080-4. PMID: 23087000; PMCID: PMC3595315.
      28. Narasimamurthy R, Hatori M, Nayak SK, Liu F, Panda S, Verma I. Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc Natl Acad Sci U S A. 2012 Jul 31; 109(31):12662-7. PMID: 22778400; PMCID: PMC3411996.
      29. Holland AJ, Fachinetti D, Da Cruz S, Zhu Q, Vitre B, Lince-Faria M, Chen D, Parish N, Verma I, Bettencourt-Dias M, Cleveland DW. Polo-like kinase 4 controls centriole duplication but does not directly regulate cytokinesis. Mol Biol Cell. 2012 May; 23(10):1838-45. PMID: 22456511; PMCID: PMC3350549.
      30. Verma I. Renato Dulbecco (1914-2012). Nature. 2012 Mar 21; 483(7390):408. PMID: 22437605.
        View in: PubMed
      31. Liu F, Xia Y, Parker AS, Verma I. IKK biology. Immunol Rev. 2012 Mar; 246(1):239-53. PMID: 22435559; PMCID: PMC3311052.
      32. Xia Y, Yeddula N, Leblanc M, Ke E, Zhang Y, Oldfield E, Shaw RJ, Verma I. Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model. Nat Cell Biol. 2012 Feb 12; 14(3):257-65. PMID: 22327365; PMCID: PMC3290728.
      33. Agemy L, Friedmann-Morvinski D, Kotamraju VR, Roth L, Sugahara KN, Girard OM, Mattrey RF, Verma I, Ruoslahti E. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc Natl Acad Sci U S A. 2011 Oct 18; 108(42):17450-5. PMID: 21969599; PMCID: PMC3198371.
      34. Hurtado de Mendoza T, Perez-Garcia CG, Kroll TT, Hoong NH, O'Leary DD, Verma I. Antiapoptotic protein Lifeguard is required for survival and maintenance of Purkinje and granular cells. Proc Natl Acad Sci U S A. 2011 Oct 11; 108(41):17189-94. PMID: 21957071; PMCID: PMC3193209.
      35. Murphy SH, Suzuki K, Downes M, Welch GL, De Jesus P, Miraglia LJ, Orth AP, Chanda SK, Evans RM, Verma I. Tumor suppressor protein (p)53, is a regulator of NF-kappaB repression by the glucocorticoid receptor. Proc Natl Acad Sci U S A. 2011 Oct 11; 108(41):17117-22. PMID: 21949408; PMCID: PMC3193198.
      36. Suzuki K, Murphy SH, Xia Y, Yokota M, Nakagomi D, Liu F, Verma I, Nakajima H. Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activation. PLoS One. 2011; 6(9):e25412. PMID: 21966524; PMCID: PMC3179515.
      37. Zhu Q, Pao GM, Huynh AM, Suh H, Tonnu N, Nederlof PM, Gage FH, Verma I. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature. 2011 Sep 07; 477(7363):179-84. PMID: 21901007; PMCID: PMC3240576.
      38. Papagiannakopoulos T, Friedmann-Morvinski D, Neveu P, Dugas JC, Gill RM, Huillard E, Liu C, Zong H, Rowitch DH, Barres BA, Verma I, Kosik KS. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene. 2012 Apr 12; 31(15):1884-95. PMID: 21874051; PMCID: PMC4160048.
      39. Woods NB, Parker AS, Moraghebi R, Lutz MK, Firth AL, Brennand KJ, Berggren WT, Raya A, Izpisúa Belmonte JC, Gage FH, Verma I. Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines. Stem Cells. 2011 Jul; 29(7):1158-64. PMID: 21544903; PMCID: PMC3254148.
      40. Hurtado de Mendoza T, Balana B, Slesinger PA, Verma I. Organotypic cerebellar cultures: apoptotic challenges and detection. J Vis Exp. 2011 May 17; (51). PMID: 21633327; PMCID: PMC3197101.
      41. Padler-Karavani V, Hurtado-Ziola N, Pu M, Yu H, Huang S, Muthana S, Chokhawala HA, Cao H, Secrest P, Friedmann-Morvinski D, Singer O, Ghaderi D, Verma I, Liu YT, Messer K, Chen X, Varki A, Schwab R. Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Res. 2011 May 01; 71(9):3352-63. PMID: 21505105; PMCID: PMC3085609.
      42. Spencer B, Marr RA, Gindi R, Potkar R, Michael S, Adame A, Rockenstein E, Verma I, Masliah E. Peripheral delivery of a CNS targeted, metalo-protease reduces aß toxicity in a mouse model of Alzheimer's disease. PLoS One. 2011 Jan 31; 6(1):e16575. PMID: 21304989; PMCID: PMC3031588.
      43. Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, Michiue H, Pastorino S, Yang M, Hoffman RM, Kesari S, Verma I. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A. 2011 Mar 15; 108(11):4274-80. PMID: 21262804; PMCID: PMC3060261.
      44. Ruiz S, Panopoulos AD, Herrerías A, Bissig KD, Lutz M, Berggren WT, Verma I, Izpisua Belmonte JC. A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Curr Biol. 2011 Jan 11; 21(1):45-52. PMID: 21167714; PMCID: PMC3034649.
      45. Kivelä AM, Mäkinen PI, Jyrkkänen HK, Mella-Aho E, Xia Y, Kansanen E, Leinonen H, Verma I, Ylä-Herttuala S, Levonen AL. Sulforaphane inhibits endothelial lipase expression through NF-?B in endothelial cells. Atherosclerosis. 2010 Nov; 213(1):122-8. PMID: 20688330.
        View in: PubMed
      46. Teo H, Ghosh S, Luesch H, Ghosh A, Wong ET, Malik N, Orth A, de Jesus P, Perry AS, Oliver JD, Tran NL, Speiser LJ, Wong M, Saez E, Schultz P, Chanda SK, Verma I, Tergaonkar V. Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression. Nat Cell Biol. 2010 Aug; 12(8):758-67. PMID: 20622870.
        View in: PubMed
      47. Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, Chisari FV, Verma I. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest. 2010 Mar; 120(3):924-30. PMID: 20179355; PMCID: PMC2827952.
      48. You Z, Shi LZ, Zhu Q, Wu P, Zhang YW, Basilio A, Tonnu N, Verma I, Berns MW, Hunter T. CtIP links DNA double-strand break sensing to resection. Mol Cell. 2009 Dec 25; 36(6):954-69. PMID: 20064462; PMCID: PMC2807415.
      49. Saberi M, Woods NB, de Luca C, Schenk S, Lu JC, Bandyopadhyay G, Verma I, Olefsky JM. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab. 2009 Nov; 10(5):419-29. PMID: 19883619; PMCID: PMC2790319.
      50. Xia Y, Padre RC, De Mendoza TH, Bottero V, Tergaonkar VB, Verma I. Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP. Proc Natl Acad Sci U S A. 2009 Feb 24; 106(8):2629-34. PMID: 19196987; PMCID: PMC2650315.
      51. Marumoto T, Tashiro A, Friedmann-Morvinski D, Scadeng M, Soda Y, Gage FH, Verma I. Development of a novel mouse glioma model using lentiviral vectors. Nat Med. 2009 Jan; 15(1):110-6. PMID: 19122659; PMCID: PMC2671237.
      52. Singer O, Verma I. Applications of lentiviral vectors for shRNA delivery and transgenesis. Curr Gene Ther. 2008 Dec; 8(6):483-8. PMID: 19075631; PMCID: PMC2774780.
      53. Spencer B, Marr RA, Rockenstein E, Crews L, Adame A, Potkar R, Patrick C, Gage FH, Verma I, Masliah E. Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice. BMC Neurosci. 2008 Nov 12; 9:109. PMID: 19014502; PMCID: PMC2596170.
      54. Suzuki K, Verma I. Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation. Cell. 2008 Aug 08; 134(3):485-95. PMID: 18692471; PMCID: PMC2586340.
      55. Tiscornia G, Singer O, Verma I. Design and Cloning of an shRNA into a Lentiviral Silencing Vector: Version A. CSH Protoc. 2008 Aug 01; 2008:pdb.prot5009. PMID: 21356884.
        View in: PubMed
      56. Tiscornia G, Singer O, Verma I. Design and Cloning of an shRNA into a Lentiviral Silencing Vector: Version B. CSH Protoc. 2008 Aug 01; 2008:pdb.prot5010. PMID: 21356885.
        View in: PubMed
      57. El-Amouri SS, Zhu H, Yu J, Marr R, Verma I, Kindy MS. Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. Am J Pathol. 2008 May; 172(5):1342-54. PMID: 18403590; PMCID: PMC2329843.
      58. McLaughlin J, Cheng D, Singer O, Lukacs RU, Radu CG, Verma I, Witte ON. Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics. Proc Natl Acad Sci U S A. 2007 Dec 18; 104(51):20501-6. PMID: 18079287; PMCID: PMC2154460.
      59. Bissig KD, Le TT, Woods NB, Verma I. Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc Natl Acad Sci U S A. 2007 Dec 18; 104(51):20507-11. PMID: 18077355; PMCID: PMC2154461.
      60. Pulivarthy SR, Tanaka N, Welsh DK, De Haro L, Verma I, Panda S. Reciprocity between phase shifts and amplitude changes in the mammalian circadian clock. Proc Natl Acad Sci U S A. 2007 Dec 18; 104(51):20356-61. PMID: 18077393; PMCID: PMC2154435.
      61. Irelan JT, Murphy TJ, DeJesus PD, Teo H, Xu D, Gomez-Ferreria MA, Zhou Y, Miraglia LJ, Rines DR, Verma I, Sharp DJ, Tergaonkar V, Chanda SK. A role for IkappaB kinase 2 in bipolar spindle assembly. Proc Natl Acad Sci U S A. 2007 Oct 23; 104(43):16940-5. PMID: 17939994; PMCID: PMC2040438.
      62. Liu AC, Welsh DK, Ko CH, Tran HG, Zhang EE, Priest AA, Buhr ED, Singer O, Meeker K, Verma I, Doyle FJ, Takahashi JS, Kay SA. Intercellular coupling confers robustness against mutations in the SCN circadian clock network. Cell. 2007 May 04; 129(3):605-16. PMID: 17482552; PMCID: PMC3749832.
      63. Singer O, Tiscornia G, Verma I. Knockdown transgenic mice generated by silencing lentiviral vectors: zona pellucida removal and subzonal injection methods. CSH Protoc. 2007 May 01; 2007:pdb.prot4756. PMID: 21357087.
        View in: PubMed
      64. Spencer BJ, Verma I. Targeted delivery of proteins across the blood-brain barrier. Proc Natl Acad Sci U S A. 2007 May 01; 104(18):7594-9. PMID: 17463083; PMCID: PMC1857226.
      65. El-Amouri SS, Zhu H, Yu J, Gage FH, Verma I, Kindy MS. Neprilysin protects neurons against Abeta peptide toxicity. Brain Res. 2007 Jun 04; 1152:191-200. PMID: 17459354; PMCID: PMC2020816.
      66. Liao W, Nguyen MT, Yoshizaki T, Favelyukis S, Patsouris D, Imamura T, Verma I, Olefsky JM. Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab. 2007 Jul; 293(1):E219-27. PMID: 17389706.
        View in: PubMed
      67. Hoffmann A, Xia Y, Verma I. Inflammatory tales of liver cancer. Cancer Cell. 2007 Feb; 11(2):99-101. PMID: 17292819.
        View in: PubMed
      68. Basak S, Kim H, Kearns JD, Tergaonkar V, O'Dea E, Werner SL, Benedict CA, Ware CF, Ghosh G, Verma I, Hoffmann A. A fourth IkappaB protein within the NF-kappaB signaling module. Cell. 2007 Jan 26; 128(2):369-81. PMID: 17254973; PMCID: PMC1831796.
      69. Ghosh S, Tergaonkar V, Rothlin CV, Correa RG, Bottero V, Bist P, Verma I, Hunter T. Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival. Cancer Cell. 2006 Sep; 10(3):215-26. PMID: 16959613.
        View in: PubMed
      70. Bottero V, Withoff S, Verma I. NF-kappaB and the regulation of hematopoiesis. Cell Death Differ. 2006 May; 13(5):785-97. PMID: 16528384.
        View in: PubMed
      71. Woods NB, Bottero V, Schmidt M, von Kalle C, Verma I. Gene therapy: therapeutic gene causing lymphoma. Nature. 2006 Apr 27; 440(7088):1123. PMID: 16641981.
        View in: PubMed
      72. Liao W, Nguyen MT, Imamura T, Singer O, Verma I, Olefsky JM. Lentiviral short hairpin ribonucleic acid-mediated knockdown of GLUT4 in 3T3-L1 adipocytes. Endocrinology. 2006 May; 147(5):2245-52. PMID: 16497797.
        View in: PubMed
      73. Tiscornia G, Singer O, Verma I. Design and cloning of lentiviral vectors expressing small interfering RNAs. Nat Protoc. 2006; 1(1):234-40. PMID: 17406238.
        View in: PubMed
      74. Singer O, Tiscornia G, Ikawa M, Verma I. Rapid generation of knockdown transgenic mice by silencing lentiviral vectors. Nat Protoc. 2006; 1(1):286-92. PMID: 17406246.
        View in: PubMed
      75. Tiscornia G, Singer O, Verma I. Production and purification of lentiviral vectors. Nat Protoc. 2006; 1(1):241-5. PMID: 17406239.
        View in: PubMed
      76. Dhawan J, Gokhale RS, Verma I. Bioscience in India: times are changing. Cell. 2005 Dec 02; 123(5):743-5. PMID: 16325565.
        View in: PubMed
      77. Tanaka N, Ikawa M, Mata NL, Verma I. Choroidal neovascularization in transgenic mice expressing prokineticin 1: an animal model for age-related macular degeneration. Mol Ther. 2006 Mar; 13(3):609-16. PMID: 16263331.
        View in: PubMed
      78. Hovatta I, Tennant RS, Helton R, Marr RA, Singer O, Redwine JM, Ellison JA, Schadt EE, Verma I, Lockhart DJ, Barlow C. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature. 2005 Dec 01; 438(7068):662-6. PMID: 16244648.
        View in: PubMed
      79. Li Q, Lu Q, Estepa G, Verma I. Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse. Proc Natl Acad Sci U S A. 2005 Nov 01; 102(44):15977-82. PMID: 16239341; PMCID: PMC1276109.
      80. Verma I. From one experiment to the next. Biotechniques. 2005 Oct; 39(4):443. PMID: 16235552.
        View in: PubMed
      81. Tergaonkar V, Correa RG, Ikawa M, Verma I. Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. Nat Cell Biol. 2005 Sep; 7(9):921-3. PMID: 16136188.
        View in: PubMed
      82. Singer O, Marr RA, Rockenstein E, Crews L, Coufal NG, Gage FH, Verma I, Masliah E. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci. 2005 Oct; 8(10):1343-9. PMID: 16136043.
        View in: PubMed
      83. Li Q, Lu Q, Bottero V, Estepa G, Morrison L, Mercurio F, Verma I. Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1). Proc Natl Acad Sci U S A. 2005 Aug 30; 102(35):12425-30. PMID: 16116086; PMCID: PMC1194954.
      84. Correa RG, Matsui T, Tergaonkar V, Rodriguez-Esteban C, Izpisua-Belmonte JC, Verma I. Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity. Curr Biol. 2005 Jul 26; 15(14):1291-5. PMID: 16051172.
        View in: PubMed
      85. Li Q, Withoff S, Verma I. Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol. 2005 Jun; 26(6):318-25. PMID: 15922948.
        View in: PubMed
      86. Blesch A, Conner J, Pfeifer A, Gasmi M, Ramirez A, Britton W, Alfa R, Verma I, Tuszynski MH. Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons. Mol Ther. 2005 Jun; 11(6):916-25. PMID: 15922962.
        View in: PubMed
      87. Dodart JC, Marr RA, Koistinaho M, Gregersen BM, Malkani S, Verma I, Paul SM. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2005 Jan 25; 102(4):1211-6. PMID: 15657137; PMCID: PMC544620.
      88. Wang L, Calcedo R, Nichols TC, Bellinger DA, Dillow A, Verma I, Wilson JM. Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy. Blood. 2005 Apr 15; 105(8):3079-86. PMID: 15637142.
        View in: PubMed
      89. Verma I, Weitzman MD. Gene therapy: twenty-first century medicine. Annu Rev Biochem. 2005; 74:711-38. PMID: 15952901.
        View in: PubMed
      90. Galimi F, Saez E, Gall J, Hoong N, Cho G, Evans RM, Verma I. Development of ecdysone-regulated lentiviral vectors. Mol Ther. 2005 Jan; 11(1):142-8. PMID: 15585415.
        View in: PubMed
      91. Galimi F, Summers RG, van Praag H, Verma I, Gage FH. A role for bone marrow-derived cells in the vasculature of noninjured CNS. Blood. 2005 Mar 15; 105(6):2400-2. PMID: 15572598.
        View in: PubMed
      92. Verma I. Nuclear factor (NF)-kappaB proteins: therapeutic targets. Ann Rheum Dis. 2004 Nov; 63 Suppl 2:ii57-ii61. PMID: 15479873; PMCID: PMC1766777.
      93. Verma I. Doping, gene transfer and sport. Mol Ther. 2004 Sep; 10(3):405. PMID: 15336640.
        View in: PubMed
      94. Verma I. Musings for young scientists. Mol Ther. 2004 Aug; 10(2):201. PMID: 15294164.
        View in: PubMed
      95. Verma I. Agbiotech: success depends on trust. Mol Ther. 2004 Jul; 10(1):1. PMID: 15233936.
        View in: PubMed
      96. Ducut Sigala JL, Bottero V, Young DB, Shevchenko A, Mercurio F, Verma I. Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science. 2004 Jun 25; 304(5679):1963-7. PMID: 15218148.
        View in: PubMed
      97. Correa RG, Tergaonkar V, Ng JK, Dubova I, Izpisua-Belmonte JC, Verma I. Characterization of NF-kappa B/I kappa B proteins in zebra fish and their involvement in notochord development. Mol Cell Biol. 2004 Jun; 24(12):5257-68. PMID: 15169890; PMCID: PMC419862.
      98. Verma I. Visa crisis hurts U.S. science. Mol Ther. 2004 Jun; 9(6):767. PMID: 15194044.
        View in: PubMed
      99. Tiscornia G, Tergaonkar V, Galimi F, Verma I. CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc Natl Acad Sci U S A. 2004 May 11; 101(19):7347-51. PMID: 15123829; PMCID: PMC409921.
      100. Singer O, Yanai A, Verma I. Silence of the genes. Proc Natl Acad Sci U S A. 2004 Apr 13; 101(15):5313-4. PMID: 15067116; PMCID: PMC399310.
      101. Kankkonen HM, Vähäkangas E, Marr RA, Pakkanen T, Laurema A, Leppänen P, Jalkanen J, Verma I, Ylä-Herttuala S. Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy. Mol Ther. 2004 Apr; 9(4):548-56. PMID: 15093185.
        View in: PubMed
      102. Tergaonkar V, Bottero V, Ikawa M, Li Q, Verma I. IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy. Mol Cell Biol. 2003 Nov; 23(22):8070-83. PMID: 14585967; PMCID: PMC262380.
      103. Takabe K, Wang L, Leal AM, Macconell LA, Wiater E, Tomiya T, Ohno A, Verma I, Vale W. Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats. Hepatology. 2003 Nov; 38(5):1107-15. PMID: 14578849.
        View in: PubMed
      104. Ikawa M, Tanaka N, Kao WW, Verma I. Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy. Mol Ther. 2003 Oct; 8(4):666-73. PMID: 14529840.
        View in: PubMed
      105. Kanazawa Y, Verma I. Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver. Proc Natl Acad Sci U S A. 2003 Sep 30; 100 Suppl 1:11850-3. PMID: 12920184; PMCID: PMC304097.
      106. Gage FH, Verma I. Stem cells at the dawn of the 21st century. Proc Natl Acad Sci U S A. 2003 Sep 30; 100 Suppl 1:11817-8. PMID: 12915737; PMCID: PMC304091.
      107. Verma I. SARS: fear of global pandemic. Mol Ther. 2003 Jun; 7(6):711. PMID: 12788644.
        View in: PubMed
      108. Shin S, Verma I. BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription. Proc Natl Acad Sci U S A. 2003 Jun 10; 100(12):7201-6. PMID: 12756300; PMCID: PMC165853.
      109. Kootstra NA, Matsumura R, Verma I. Efficient production of human FVIII in hemophilic mice using lentiviral vectors. Mol Ther. 2003 May; 7(5 Pt 1):623-31. PMID: 12718905.
        View in: PubMed
      110. Marr RA, Rockenstein E, Mukherjee A, Kindy MS, Hersh LB, Gage FH, Verma I, Masliah E. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci. 2003 Mar 15; 23(6):1992-6. PMID: 12657655.
        View in: PubMed
      111. Tiscornia G, Singer O, Ikawa M, Verma I. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci U S A. 2003 Feb 18; 100(4):1844-8. PMID: 12552109; PMCID: PMC149921.
      112. Kootstra NA, Munk C, Tonnu N, Landau NR, Verma I. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci U S A. 2003 Feb 04; 100(3):1298-303. PMID: 12547912; PMCID: PMC298767.
      113. Verma I. Making the promise a reality. Mol Ther. 2002 Dec; 6(6):695. PMID: 12498763.
        View in: PubMed
      114. Xia Y, Pao GM, Chen HW, Verma I, Hunter T. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J Biol Chem. 2003 Feb 14; 278(7):5255-63. PMID: 12431996.
        View in: PubMed
      115. Verma I. Success and setback: another adverse event. Mol Ther. 2002 Nov; 6(5):565-6. PMID: 12409253.
        View in: PubMed
      116. Galimi F, Noll M, Kanazawa Y, Lax T, Chen C, Grompe M, Verma I. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors. Blood. 2002 Oct 15; 100(8):2732-6. PMID: 12351379.
        View in: PubMed
      117. Verma I. Politics and scientific publishing: noli me tangere. Mol Ther. 2002 Oct; 6(4):431. PMID: 12377181.
        View in: PubMed
      118. Li Q, Verma I. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002 Oct; 2(10):725-34. PMID: 12360211.
        View in: PubMed
      119. MacKenzie TC, Kobinger GP, Kootstra NA, Radu A, Sena-Esteves M, Bouchard S, Wilson JM, Verma I, Flake AW. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. Mol Ther. 2002 Sep; 6(3):349-58. PMID: 12231171.
        View in: PubMed
      120. Pan D, Gunther R, Duan W, Wendell S, Kaemmerer W, Kafri T, Verma I, Whitley CB. Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow. Mol Ther. 2002 Jul; 6(1):19-29. PMID: 12095299.
        View in: PubMed
      121. Verma I. Hypothesis-driven science. Mol Ther. 2002 Jul; 6(1):1. PMID: 12095295.
        View in: PubMed
      122. Verma I. Do not ban therapeutic cloning. Mol Ther. 2002 Jun; 5(6):651. PMID: 12027544.
        View in: PubMed
      123. Ikawa M, Tergaonkar V, Ogura A, Ogonuki N, Inoue K, Verma I. Restoration of spermatogenesis by lentiviral gene transfer: offspring from infertile mice. Proc Natl Acad Sci U S A. 2002 May 28; 99(11):7524-9. PMID: 12032316; PMCID: PMC124271.
      124. Verma I. Politics and AIDS: a bad mix. Mol Ther. 2002 May; 5(5 Pt 1):485. PMID: 11991737.
        View in: PubMed
      125. Verma I. Censorship of scientific publications: a bad idea. Mol Ther. 2002 Apr; 5(4):337. PMID: 11945057.
        View in: PubMed
      126. Leal AM, Takabe K, Wang L, Donaldson CJ, MacConell LA, Bilezikjian LM, Verma I, Vale W. Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo. Endocrinology. 2002 Mar; 143(3):964-9. PMID: 11861519.
        View in: PubMed
      127. Verma I. A gene therapy institute for NIH? Mol Ther. 2002 Mar; 5(3):213. PMID: 11863406.
        View in: PubMed
      128. Pfeifer A, Ikawa M, Dayn Y, Verma I. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci U S A. 2002 Feb 19; 99(4):2140-5. PMID: 11854510; PMCID: PMC122332.
      129. Kaspar BK, Vissel B, Bengoechea T, Crone S, Randolph-Moore L, Muller R, Brandon EP, Schaffer D, Verma I, Lee KF, Heinemann SF, Gage FH. Adeno-associated virus effectively mediates conditional gene modification in the brain. Proc Natl Acad Sci U S A. 2002 Feb 19; 99(4):2320-5. PMID: 11842206; PMCID: PMC122363.
      130. Verma I. Biopiracy: distrust widens the rich-poor divide. Mol Ther. 2002 Feb; 5(2):95. PMID: 11829514.
        View in: PubMed
      131. Kootstra NA, Verma I. Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol. 2003; 43:413-39. PMID: 12359866.
        View in: PubMed
      132. Galimi F, Verma I. Opportunities for the use of lentiviral vectors in human gene therapy. Curr Top Microbiol Immunol. 2002; 261:245-54. PMID: 11892251.
        View in: PubMed
      133. Verma I. Gene therapy and jurisprudence. Mol Ther. 2001 Nov; 4(5):393. PMID: 11708873.
        View in: PubMed
      134. Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma I. Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc Natl Acad Sci U S A. 2001 Sep 25; 98(20):11450-5. PMID: 11553794; PMCID: PMC58750.
      135. Verma I. Are the benefits of stem cells being oversold? Mol Ther. 2001 Sep; 4(3):161. PMID: 11545604.
        View in: PubMed
      136. Lamberti C, Lin KM, Yamamoto Y, Verma U, Verma I, Byers S, Gaynor RB. Regulation of beta-catenin function by the IkappaB kinases. J Biol Chem. 2001 Nov 09; 276(45):42276-86. PMID: 11527961.
        View in: PubMed
      137. Verma I. Adverse event reporting: essential for science and public trust. Mol Ther. 2001 Aug; 4(2):83. PMID: 11482977.
        View in: PubMed
      138. Verma I. Germline gene therapy: yes or no? Mol Ther. 2001 Jul; 4(1):1. PMID: 11472097.
        View in: PubMed
      139. Verma I. Ombudsman or hotline for Gene therapy clinical trials? Mol Ther. 2001 Jun; 3(6):817-8. PMID: 11407893.
        View in: PubMed
      140. McAllister-Lucas LM, Inohara N, Lucas PC, Ruland J, Benito A, Li Q, Chen S, Chen FF, Yamaoka S, Verma I, Mak TW, Núñez G. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J Biol Chem. 2001 Aug 17; 276(33):30589-97. PMID: 11387339.
        View in: PubMed
      141. Verma I. Stem cell research: win, win, win by keeping politics out. Mol Ther. 2001 May; 3(5 Pt 1):641. PMID: 11356067.
        View in: PubMed
      142. Ruffner H, Joazeiro CA, Hemmati D, Hunter T, Verma I. Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc Natl Acad Sci U S A. 2001 Apr 24; 98(9):5134-9. PMID: 11320250; PMCID: PMC33176.
      143. Verma I. Pharma + profits = continued aids epidemic. Mol Ther. 2001 Apr; 3(4):419. PMID: 11319899.
        View in: PubMed
      144. Pfeifer A, Kessler T, Yang M, Baranov E, Kootstra N, Cheresh DA, Hoffman RM, Verma I. Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. Mol Ther. 2001 Mar; 3(3):319-22. PMID: 11273773.
        View in: PubMed
      145. Xu K, Ma H, McCown TJ, Verma I, Kafri T. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol Ther. 2001 Jan; 3(1):97-104. PMID: 11162316.
        View in: PubMed
      146. Pfeifer A, Verma I. Gene therapy: promises and problems. Annu Rev Genomics Hum Genet. 2001; 2:177-211. PMID: 11701648.
        View in: PubMed
      147. Verma I. Gene therapy: the need for basic science. Mol Ther. 2000 Dec; 2(6):531. PMID: 11124051.
        View in: PubMed
      148. Verma I. A tumultuous year for gene therapy. Mol Ther. 2000 Nov; 2(5):415-6. PMID: 11082313.
        View in: PubMed
      149. Somia N, Verma I. Gene therapy: trials and tribulations. Nat Rev Genet. 2000 Nov; 1(2):91-9. PMID: 11253666.
        View in: PubMed
      150. Pfeifer A, Kessler T, Silletti S, Cheresh DA, Verma I. Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2. Proc Natl Acad Sci U S A. 2000 Oct 24; 97(22):12227-32. PMID: 11035804; PMCID: PMC17323.
      151. Verma I. AIDS: are we doing enough? Mol Ther. 2000 Oct; 2(4):299. PMID: 11020343.
        View in: PubMed
      152. Verma I. Gene therapy: public education. Mol Ther. 2000 Sep; 2(3):177. PMID: 10985946.
        View in: PubMed
      153. Verma I, Gage FH. Genome and gene therapy. Mol Ther. 2000 Aug; 2(2):95. PMID: 10947933.
        View in: PubMed
      154. Li Q, Estepa G, Memet S, Israel A, Verma I. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes Dev. 2000 Jul 15; 14(14):1729-33. PMID: 10898787; PMCID: PMC316792.
      155. Pando MP, Verma I. Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha. J Biol Chem. 2000 Jul 14; 275(28):21278-86. PMID: 10801847.
        View in: PubMed
      156. Kafri T, van Praag H, Gage FH, Verma I. Lentiviral vectors: regulated gene expression. Mol Ther. 2000 Jun; 1(6):516-21. PMID: 10933976.
        View in: PubMed
      157. Verma I. Gene therapy: beyond 2000. Mol Ther. 2000 Jun; 1(6):493. PMID: 10933971.
        View in: PubMed
      158. Somia NV, Miyoshi H, Schmitt MJ, Verma I. Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping. J Virol. 2000 May; 74(9):4420-4. PMID: 10756057; PMCID: PMC111959.
      159. Wang L, Nichols TC, Read MS, Bellinger DA, Verma I. Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. Mol Ther. 2000 Feb; 1(2):154-8. PMID: 10933925.
        View in: PubMed
      160. Pao GM, Janknecht R, Ruffner H, Hunter T, Verma I. CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci U S A. 2000 Feb 01; 97(3):1020-5. PMID: 10655477; PMCID: PMC15508.
      161. Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma I, Oda H, Nakamura K, Tanaka S. Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J Cell Biol. 2000 Jan 24; 148(2):333-42. PMID: 10648566; PMCID: PMC2174281.
      162. Naldini L, Verma I. Lentiviral vectors. Adv Virus Res. 2000; 55:599-609. PMID: 11050959.
        View in: PubMed
      163. Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma I. Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations. Proc Natl Acad Sci U S A. 1999 Nov 23; 96(24):13920-5. PMID: 10570174; PMCID: PMC24166.
      164. Somia NV, Schmitt MJ, Vetter DE, Van Antwerp D, Heinemann SF, Verma I. LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proc Natl Acad Sci U S A. 1999 Oct 26; 96(22):12667-72. PMID: 10535980; PMCID: PMC23041.
      165. Takahashi M, Miyoshi H, Verma I, Gage FH. Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J Virol. 1999 Sep; 73(9):7812-6. PMID: 10438872; PMCID: PMC104309.
      166. Ruffner H, Jiang W, Craig AG, Hunter T, Verma I. BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Mol Cell Biol. 1999 Jul; 19(7):4843-54. PMID: 10373534; PMCID: PMC84283.
      167. Li Q, Lu Q, Hwang JY, Büscher D, Lee KF, Izpisua-Belmonte JC, Verma I. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 1999 May 15; 13(10):1322-8. PMID: 10346820; PMCID: PMC316728.
      168. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma I. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science. 1999 Apr 09; 284(5412):321-5. PMID: 10195897.
        View in: PubMed
      169. Wang L, Takabe K, Bidlingmaier SM, Ill CR, Verma I. Sustained correction of bleeding disorder in hemophilia B mice by gene therapy. Proc Natl Acad Sci U S A. 1999 Mar 30; 96(7):3906-10. PMID: 10097136; PMCID: PMC22393.
      170. Somia NV, Kafri T, Verma I. Piecing together more efficient gene expression. Nat Biotechnol. 1999 Mar; 17(3):224-5. PMID: 10096283.
        View in: PubMed
      171. Miyoshi H, Smith KA, Mosier DE, Verma I, Torbett BE. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science. 1999 Jan 29; 283(5402):682-6. PMID: 9924027.
        View in: PubMed
      172. Kafri T, van Praag H, Ouyang L, Gage FH, Verma I. A packaging cell line for lentivirus vectors. J Virol. 1999 Jan; 73(1):576-84. PMID: 9847362; PMCID: PMC103863.
      173. Verma I. From reverse transcriptase to gene therapy: a marvelous journey. Harvey Lect. 1999-2000; 95:43-66. PMID: 11446110.
        View in: PubMed
      174. Gallichan WS, Kafri T, Krahl T, Verma I, Sarvetnick N. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther. 1998 Dec 10; 9(18):2717-26. PMID: 9874270.
        View in: PubMed
      175. Miyoshi H, Blömer U, Takahashi M, Gage FH, Verma I. Development of a self-inactivating lentivirus vector. J Virol. 1998 Oct; 72(10):8150-7. PMID: 9733856; PMCID: PMC110156.
      176. Schwarz EM, Badorff C, Hiura TS, Wessely R, Badorff A, Verma I, Knowlton KU. NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice. J Virol. 1998 Jul; 72(7):5654-60. PMID: 9621024; PMCID: PMC110231.
      177. Kanegae Y, Tavares AT, Izpisúa Belmonte JC, Verma I. Role of Rel/NF-kappaB transcription factors during the outgrowth of the vertebrate limb. Nature. 1998 Apr 09; 392(6676):611-4. PMID: 9560158.
        View in: PubMed
      178. Blömer U, Kafri T, Randolph-Moore L, Verma I, Gage FH. Bcl-xL protects adult septal cholinergic neurons from axotomized cell death. Proc Natl Acad Sci U S A. 1998 Mar 03; 95(5):2603-8. PMID: 9482933; PMCID: PMC19429.
      179. Van Antwerp DJ, Martin SJ, Verma I, Green DR. Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol. 1998 Mar; 8(3):107-11. PMID: 9695819.
        View in: PubMed
      180. Kafri T, Blömer U, Peterson DA, Gage FH, Verma I. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet. 1997 Nov; 17(3):314-7. PMID: 9354796.
        View in: PubMed
      181. Verma I, Stevenson J. IkappaB kinase: beginning, not the end. Proc Natl Acad Sci U S A. 1997 Oct 28; 94(22):11758-60. PMID: 9342307; PMCID: PMC33775.
      182. Wang L, Zoppè M, Hackeng TM, Griffin JH, Lee KF, Verma I. A factor IX-deficient mouse model for hemophilia B gene therapy. Proc Natl Acad Sci U S A. 1997 Oct 14; 94(21):11563-6. PMID: 9326649; PMCID: PMC23538.
      183. Verma I, Somia N. Gene therapy -- promises, problems and prospects. Nature. 1997 Sep 18; 389(6648):239-42. PMID: 9305836.
        View in: PubMed
      184. Miyoshi H, Takahashi M, Gage FH, Verma I. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci U S A. 1997 Sep 16; 94(19):10319-23. PMID: 9294208; PMCID: PMC23360.
      185. Blömer U, Naldini L, Kafri T, Trono D, Verma I, Gage FH. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol. 1997 Sep; 71(9):6641-9. PMID: 9261386; PMCID: PMC191942.
      186. Tashiro K, Pando MP, Kanegae Y, Wamsley PM, Inoue S, Verma I. Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5 in the degradation of IkappaBalpha. Proc Natl Acad Sci U S A. 1997 Jul 22; 94(15):7862-7. PMID: 9223278; PMCID: PMC21520.
      187. Ruffner H, Verma I. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci U S A. 1997 Jul 08; 94(14):7138-43. PMID: 9207057; PMCID: PMC23770.
      188. Schwarz EM, Krimpenfort P, Berns A, Verma I. Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev. 1997 Jan 15; 11(2):187-97. PMID: 9009202.
        View in: PubMed
      189. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma I. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 1996 Nov 01; 274(5288):787-9. PMID: 8864120.
        View in: PubMed
      190. Van Antwerp DJ, Verma I. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required. Mol Cell Biol. 1996 Nov; 16(11):6037-45. PMID: 8887633; PMCID: PMC231606.
      191. Naldini L, Blömer U, Gage FH, Trono D, Verma I. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A. 1996 Oct 15; 93(21):11382-8. PMID: 8876144; PMCID: PMC38066.
      192. Naviaux RK, Costanzi E, Haas M, Verma I. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol. 1996 Aug; 70(8):5701-5. PMID: 8764092; PMCID: PMC190538.
      193. Schwarz EM, Van Antwerp D, Verma I. Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha. Mol Cell Biol. 1996 Jul; 16(7):3554-9. PMID: 8668171; PMCID: PMC231350.
      194. Verma I. "Green light" for gene transfer. Nat Biotechnol. 1996 May; 14(5):576. PMID: 9630941.
        View in: PubMed
      195. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma I, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996 Apr 12; 272(5259):263-7. PMID: 8602510.
        View in: PubMed
      196. Blömer U, Naldini L, Verma I, Trono D, Gage FH. Applications of gene therapy to the CNS. Hum Mol Genet. 1996; 5 Spec No:1397-404. PMID: 8875243.
        View in: PubMed
      197. Verma I, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 1995 Nov 15; 9(22):2723-35. PMID: 7590248.
        View in: PubMed
      198. Barroga CF, Stevenson JK, Schwarz EM, Verma I. Constitutive phosphorylation of I kappa B alpha by casein kinase II. Proc Natl Acad Sci U S A. 1995 Aug 15; 92(17):7637-41. PMID: 7644469; PMCID: PMC41200.
      199. Somia NV, Zoppé M, Verma I. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci U S A. 1995 Aug 01; 92(16):7570-4. PMID: 7638232; PMCID: PMC41381.
      200. Dai Y, Schwarz EM, Gu D, Zhang WW, Sarvetnick N, Verma I. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1401-5. PMID: 7877990; PMCID: PMC42527.
      201. Miyamoto S, Verma I. Rel/NF-kappa B/I kappa B story. Adv Cancer Res. 1995; 66:255-92. PMID: 7793317.
        View in: PubMed
      202. Miyamoto S, Cauley K, Verma I. Ultraviolet cross-linking of DNA binding proteins. Methods Enzymol. 1995; 254:632-41. PMID: 8531720.
        View in: PubMed
      203. Miyamoto S, Maki M, Schmitt MJ, Hatanaka M, Verma I. Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B. Proc Natl Acad Sci U S A. 1994 Dec 20; 91(26):12740-4. PMID: 7809113; PMCID: PMC45515.
      204. Verma I. Gene therapy: hopes, hypes, and hurdles. Mol Med. 1994 Nov; 1(1):2-3. PMID: 8790596; PMCID: PMC2229927.
      205. Bengal E, Flores O, Rangarajan PN, Chen A, Weintraub H, Verma I. Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro. Proc Natl Acad Sci U S A. 1994 Jun 21; 91(13):6221-5. PMID: 8016142; PMCID: PMC44170.
      206. Miyamoto S, Schmitt MJ, Verma I. Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation. Proc Natl Acad Sci U S A. 1994 May 24; 91(11):5056-60. PMID: 8197184; PMCID: PMC43930.
      207. Miyamoto S, Chiao PJ, Verma I. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines. Mol Cell Biol. 1994 May; 14(5):3276-82. PMID: 8164680; PMCID: PMC358694.
      208. Cauley K, Verma I. Kappa B enhancer-binding complexes that do not contain NF-kappa B are developmentally regulated in mammalian brain. Proc Natl Acad Sci U S A. 1994 Jan 04; 91(1):390-4. PMID: 8278399; PMCID: PMC42953.
      209. Chiao PJ, Miyamoto S, Verma I. Autoregulation of I kappa B alpha activity. Proc Natl Acad Sci U S A. 1994 Jan 04; 91(1):28-32. PMID: 8278379; PMCID: PMC42879.
      210. Wisdon R, Verma I. Transformation by Fos proteins requires a C-terminal transactivation domain. Mol Cell Biol. 1993 Dec; 13(12):7429-38. PMID: 7504176; PMCID: PMC364814.
      211. Nabel GJ, Verma I. Proposed NF-kappa B/I kappa B family nomenclature. Genes Dev. 1993 Nov; 7(11):2063. PMID: 8224837.
        View in: PubMed
      212. Kerr LD, Ransone LJ, Wamsley P, Schmitt MJ, Boyer TG, Zhou Q, Berk AJ, Verma I. Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B. Nature. 1993 Sep 30; 365(6445):412-9. PMID: 8413585.
        View in: PubMed
      213. Wisdom R, Verma I. Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation. Mol Cell Biol. 1993 May; 13(5):2635-43. PMID: 8474434; PMCID: PMC359630.
      214. Ransone LJ, Kerr LD, Schmitt MJ, Wamsley P, Verma I. The bZIP domains of Fos and Jun mediate a physical association with the TATA box-binding protein. Gene Expr. 1993; 3(1):37-48. PMID: 7685215.
        View in: PubMed
      215. Léveillard T, Verma I. Diverse molecular mechanisms of inhibition of NF-kappa B/DNA binding complexes by I kappa B proteins. Gene Expr. 1993; 3(2):135-50. PMID: 8268718.
        View in: PubMed
      216. Dwarki VJ, Malone RW, Verma I. Cationic liposome-mediated RNA transfection. Methods Enzymol. 1993; 217:644-54. PMID: 7682647.
        View in: PubMed
      217. Kerr LD, Duckett CS, Wamsley P, Zhang Q, Chiao P, Nabel G, McKeithan TW, Baeuerle PA, Verma I. The proto-oncogene bcl-3 encodes an I kappa B protein. Genes Dev. 1992 Dec; 6(12A):2352-63. PMID: 1459457.
        View in: PubMed
      218. Dai Y, Roman M, Naviaux RK, Verma I. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci U S A. 1992 Nov 15; 89(22):10892-5. PMID: 1332058; PMCID: PMC50448.
      219. Naviaux RK, Verma I. Retroviral vectors for persistent expression in vivo. Curr Opin Biotechnol. 1992 Oct; 3(5):540-7. PMID: 1368938.
        View in: PubMed
      220. Naughton BA, Dai Y, Sibanda B, Scharfmann R, San Roman J, Zeigler F, Verma I. Long-term expression of a retrovirally introduced beta-galactosidase gene in rodent cells implanted in vivo using biodegradable polymer meshes. Somat Cell Mol Genet. 1992 Sep; 18(5):451-62. PMID: 1475711.
        View in: PubMed
      221. Kerr LD, Inoue J, Verma I. Signal transduction: the nuclear target. Curr Opin Cell Biol. 1992 Jun; 4(3):496-501. PMID: 1497922.
        View in: PubMed
      222. Inoue J, Kerr LD, Rashid D, Davis N, Bose HR, Verma I. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc Natl Acad Sci U S A. 1992 May 15; 89(10):4333-7. PMID: 1533932; PMCID: PMC49076.
      223. Roman M, Axelrod JH, Dai Y, Naviaux RK, Friedmann T, Verma I. Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle. Somat Cell Mol Genet. 1992 May; 18(3):247-58. PMID: 1496420.
        View in: PubMed
      224. Wisdom R, Yen J, Rashid D, Verma I. Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains. Genes Dev. 1992 Apr; 6(4):667-75. PMID: 1373118.
        View in: PubMed
      225. Inoue J, Kerr LD, Kakizuka A, Verma I. I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. Cell. 1992 Mar 20; 68(6):1109-20. PMID: 1339305.
        View in: PubMed
      226. Miyanohara A, Johnson PA, Elam RL, Dai Y, Witztum JL, Verma I, Friedmann T. Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX. New Biol. 1992 Mar; 4(3):238-46. PMID: 1316145.
        View in: PubMed
      227. Tratner I, Ofir R, Verma I. Alteration of a cyclic AMP-dependent protein kinase phosphorylation site in the c-Fos protein augments its transforming potential. Mol Cell Biol. 1992 Mar; 12(3):998-1006. PMID: 1545828; PMCID: PMC369532.
      228. Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott SJ, Weintraub H, Verma I. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell. 1992 Feb 07; 68(3):507-19. PMID: 1310896.
        View in: PubMed
      229. Verma I, Inoue J, Kerr LD, Ofir R, Ransone LJ. Oncogenes as transcription factors:implications for signal transduction. Prog Clin Biol Res. 1992; 376:41-59. PMID: 1528929.
        View in: PubMed
      230. Tratner I, Verma I. Identification of a nuclear targeting sequence in the Fos protein. Oncogene. 1991 Nov; 6(11):2049-53. PMID: 1945410.
        View in: PubMed
      231. Kerr LD, Inoue J, Davis N, Link E, Baeuerle PA, Bose HR, Verma I. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation. Genes Dev. 1991 Aug; 5(8):1464-76. PMID: 1907941.
        View in: PubMed
      232. Yen J, Wisdom RM, Tratner I, Verma I. An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc Natl Acad Sci U S A. 1991 Jun 15; 88(12):5077-81. PMID: 1905017; PMCID: PMC51814.
      233. Scharfmann R, Axelrod JH, Verma I. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc Natl Acad Sci U S A. 1991 Jun 01; 88(11):4626-30. PMID: 1905011; PMCID: PMC51718.
      234. Verma I, Naviaux RK. Human gene therapy. Curr Opin Genet Dev. 1991 Jun; 1(1):54-9. PMID: 1840879.
        View in: PubMed
      235. Inoue J, Kerr LD, Ransone LJ, Bengal E, Hunter T, Verma I. c-rel activates but v-rel suppresses transcription from kappa B sites. Proc Natl Acad Sci U S A. 1991 May 01; 88(9):3715-9. PMID: 2023921; PMCID: PMC51523.
      236. Ofir R, Dwarki VJ, Rashid D, Verma I. CREB represses transcription of fos promoter: role of phosphorylation. Gene Expr. 1991 Apr; 1(1):55-60. PMID: 1840296.
        View in: PubMed
      237. Verma I. Gene therapy. Sci Am. 1990 Nov; 263(5):68-72, 81-4. PMID: 2255890.
        View in: PubMed
      238. Wisdom R, Verma I. Revertants of v-fos-transformed rat fibroblasts: suppression of transformation is dominant. Mol Cell Biol. 1990 Nov; 10(11):5626-33. PMID: 2172782; PMCID: PMC361322.
      239. Ofir R, Dwarki VJ, Rashid D, Verma I. Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter. Nature. 1990 Nov 01; 348(6296):80-2. PMID: 2122257.
        View in: PubMed
      240. Bull P, Morley KL, Hoekstra MF, Hunter T, Verma I. The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain. Mol Cell Biol. 1990 Oct; 10(10):5473-85. PMID: 2204816; PMCID: PMC361256.
      241. Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma I, Evans RM. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell. 1990 Sep 21; 62(6):1217-26. PMID: 2169353.
        View in: PubMed
      242. Ransone LJ, Wamsley P, Morley KL, Verma I. Domain swapping reveals the modular nature of Fos, Jun, and CREB proteins. Mol Cell Biol. 1990 Sep; 10(9):4565-73. PMID: 2143806; PMCID: PMC361044.
      243. Axelrod JH, Read MS, Brinkhous KM, Verma I. Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs. Proc Natl Acad Sci U S A. 1990 Jul; 87(13):5173-7. PMID: 2367529; PMCID: PMC54284.
      244. Li CL, Dwarki VJ, Verma I. Expression of human alpha-globin and mouse/human hybrid beta-globin genes in murine hemopoietic stem cells transduced by recombinant retroviruses. Proc Natl Acad Sci U S A. 1990 Jun; 87(11):4349-53. PMID: 2349242; PMCID: PMC54107.
      245. Lamph WW, Dwarki VJ, Ofir R, Montminy M, Verma I. Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation. Proc Natl Acad Sci U S A. 1990 Jun; 87(11):4320-4. PMID: 2140898; PMCID: PMC54101.
      246. Ransone LJ, Visvader J, Wamsley P, Verma I. Trans-dominant negative mutants of Fos and Jun. Proc Natl Acad Sci U S A. 1990 May; 87(10):3806-10. PMID: 2111017; PMCID: PMC53992.
      247. Tratner I, De Togni P, Sassone-Corsi P, Verma I. Characterization and purification of human fos protein generated in insect cells with a baculoviral expression vector. J Virol. 1990 Feb; 64(2):499-508. PMID: 2104941; PMCID: PMC249137.
      248. Ransone LJ, Verma I. Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol. 1990; 6:539-57. PMID: 2125830.
        View in: PubMed
      249. Atwater JA, Wisdom R, Verma I. Regulated mRNA stability. Annu Rev Genet. 1990; 24:519-41. PMID: 2088178.
        View in: PubMed
      250. Kindy MS, Verma I. Developmental expression of the Xenopus laevis fos protooncogene. Cell Growth Differ. 1990 Jan; 1(1):27-37. PMID: 2127691.
        View in: PubMed
      251. Verma I, Ransone LJ, Visvader J, Sassone-Corsi P, Lamph WW. fos-jun conspiracy: implications for the cell. Ciba Found Symp. 1990; 150:128-37; discussion 137-46. PMID: 2115424.
        View in: PubMed
      252. Dwarki VJ, Montminy M, Verma I. Both the basic region and the 'leucine zipper' domain of the cyclic AMP response element binding (CREB) protein are essential for transcriptional activation. EMBO J. 1990 Jan; 9(1):225-32. PMID: 2136830; PMCID: PMC551651.
      253. Valerio D, Einerhand MP, Wamsley PM, Bakx TA, Li CL, Verma I. Retrovirus-mediated gene transfer into embryonal carcinoma and hemopoietic stem cells: expression from a hybrid long terminal repeat. Gene. 1989 Dec 14; 84(2):419-27. PMID: 2612913.
        View in: PubMed
      254. Bull P, Hunter T, Verma I. Transcriptional induction of the murine c-rel gene with serum and phorbol-12-myristate-13-acetate in fibroblasts. Mol Cell Biol. 1989 Nov; 9(11):5239-43. PMID: 2601720; PMCID: PMC363680.
      255. Malone RW, Felgner PL, Verma I. Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci U S A. 1989 Aug; 86(16):6077-81. PMID: 2762315; PMCID: PMC297778.
      256. Sassone-Corsi P, Der CJ, Verma I. ras-induced neuronal differentiation of PC12 cells: possible involvement of fos and jun. Mol Cell Biol. 1989 Aug; 9(8):3174-83. PMID: 2507902; PMCID: PMC362361.
      257. Fujii M, Shalloway D, Verma I. Gene regulation by tyrosine kinases: src protein activates various promoters, including c-fos. Mol Cell Biol. 1989 Jun; 9(6):2493-9. PMID: 2474755; PMCID: PMC362322.
      258. Ransone LJ, Visvader J, Sassone-Corsi P, Verma I. Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins. Genes Dev. 1989 Jun; 3(6):770-81. PMID: 2501150.
        View in: PubMed
      259. Ransone LJ, Verma I. Association of nuclear oncoproteins fos and jun. Curr Opin Cell Biol. 1989 Jun; 1(3):536-40. PMID: 2516738.
        View in: PubMed
      260. Visvader J, Verma I. Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes. Mol Cell Biol. 1989 Mar; 9(3):1336-41. PMID: 2524648; PMCID: PMC362728.
      261. Raymond V, Atwater JA, Verma I. Removal of an mRNA destabilizing element correlates with the increased oncogenicity of proto-oncogene fos. Oncogene Res. 1989; 5(1):1-12. PMID: 2506502.
        View in: PubMed
      262. Verma I, Ransone LJ, Visvader J, Sassone-Corsi P, Lamph WW. fos-jun Conspiracy: implications for the cell. Princess Takamatsu Symp. 1989; 20:119-26. PMID: 2518685.
        View in: PubMed
      263. Ransone LJ, Visvader J, Lamph WW, Sassone-Corsi P, Verma I. fos and jun interaction: the role of the leucine zipper. Int J Cancer Suppl. 1989; 4:10-21. PMID: 2509385.
        View in: PubMed
      264. Sassone-Corsi P, Ransone LJ, Lamph WW, Verma I. Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain. Nature. 1988 Dec 15; 336(6200):692-5. PMID: 3143919.
        View in: PubMed
      265. Visvader J, Sassone-Corsi P, Verma I. Two adjacent promoter elements mediate nerve growth factor activation of the c-fos gene and bind distinct nuclear complexes. Proc Natl Acad Sci U S A. 1988 Dec; 85(24):9474-8. PMID: 2849107; PMCID: PMC282775.
      266. Sassone-Corsi P, Visvader J, Ferland L, Mellon PL, Verma I. Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev. 1988 Dec; 2(12A):1529-38. PMID: 2850967.
        View in: PubMed
      267. Fujii M, Sassone-Corsi P, Verma I. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A. 1988 Nov; 85(22):8526-30. PMID: 2847164; PMCID: PMC282491.
      268. Lamph WW, Wamsley P, Sassone-Corsi P, Verma I. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature. 1988 Aug 18; 334(6183):629-31. PMID: 2457172.
        View in: PubMed
      269. Sassone-Corsi P, Lamph WW, Kamps M, Verma I. fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell. 1988 Aug 12; 54(4):553-60. PMID: 3135941.
        View in: PubMed
      270. Sassone-Corsi P, Sisson JC, Verma I. Transcriptional autoregulation of the proto-oncogene fos. Nature. 1988 Jul 28; 334(6180):314-9. PMID: 2839774.
        View in: PubMed
      271. St Louis D, Verma I. An alternative approach to somatic cell gene therapy. Proc Natl Acad Sci U S A. 1988 May; 85(9):3150-4. PMID: 3283738; PMCID: PMC280161.
      272. De Togni P, Niman H, Raymond V, Sawchenko P, Verma I. Detection of fos protein during osteogenesis by monoclonal antibodies. Mol Cell Biol. 1988 May; 8(5):2251-6. PMID: 3133556; PMCID: PMC363412.
      273. Sassone-Corsi P, Lamph WW, Verma I. Regulation of proto-oncogene fos: a paradigm for early response genes. Cold Spring Harb Symp Quant Biol. 1988; 53 Pt 2:749-60. PMID: 3151187.
        View in: PubMed
      274. Barber JR, Sassone-Corsi P, Verma I. Proto-oncogene fos expression and post-translational modification. Prog Clin Biol Res. 1988; 266:23-37. PMID: 3132724.
        View in: PubMed
      275. Verma I, Sassone-Corsi P. Proto-oncogene fos: complex but versatile regulation. Cell. 1987 Nov 20; 51(4):513-4. PMID: 3119222.
        View in: PubMed
      276. Barber JR, Verma I. Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum. Mol Cell Biol. 1987 Jun; 7(6):2201-11. PMID: 3110603; PMCID: PMC365344.
      277. Billestrup N, Mitchell RL, Vale W, Verma I. Growth hormone-releasing factor induces c-fos expression in cultured primary pituitary cells. Mol Endocrinol. 1987 Apr; 1(4):300-5. PMID: 3135482.
        View in: PubMed
      278. Verma I, Graham WR. The fos oncogene. Adv Cancer Res. 1987; 49:29-52. PMID: 2823543.
        View in: PubMed
      279. Barber JR, Sassone-Corsi P, Verma I. Proto-oncogene fos: factors affecting expression and covalent modification of the gene product. Ann N Y Acad Sci. 1987; 511:117-30. PMID: 2830821.
        View in: PubMed
      280. Mitchell RL, Henning-Chubb C, Huberman E, Verma I. c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages. Cell. 1986 May 23; 45(4):497-504. PMID: 3085953.
        View in: PubMed
      281. Mitchell RL, Hanks SK, Verma I. Proto-oncogene fos: an inducible multifaceted gene. Symp Fundam Cancer Res. 1986; 39:99-113. PMID: 2827284.
        View in: PubMed
      282. Verma I, Mitchell RL, Sassone-Corsi P. Proto-oncogene fos: an inducible gene. Princess Takamatsu Symp. 1986; 17:279-90. PMID: 3332016.
        View in: PubMed
      283. Deschamps J, Mitchell RL, Meijlink F, Kruijer W, Schubert D, Verma I. Proto-oncogene fos is expressed during development, differentiation, and growth. Cold Spring Harb Symp Quant Biol. 1985; 50:733-45. PMID: 3868506.
        View in: PubMed
      284. Mitchell RL, Zokas L, Schreiber RD, Verma I. Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation. Cell. 1985 Jan; 40(1):209-17. PMID: 3881183.
        View in: PubMed
      285. Miller AD, Ong ES, Rosenfeld MG, Verma I, Evans RM. Infectious and selectable retrovirus containing an inducible rat growth hormone minigene. Science. 1984 Sep 07; 225(4666):993-8. PMID: 6089340.
        View in: PubMed
      286. Miller AD, Eckner RJ, Jolly DJ, Friedmann T, Verma I. Expression of a retrovirus encoding human HPRT in mice. Science. 1984 Aug 10; 225(4662):630-2. PMID: 6377498.
        View in: PubMed
      287. Curran T, Verma I. FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product. Virology. 1984 May; 135(1):218-28. PMID: 6203214.
        View in: PubMed
      288. Slamon DJ, deKernion JB, Verma I, Cline MJ. Expression of cellular oncogenes in human malignancies. Science. 1984 Apr 20; 224(4646):256-62. PMID: 6538699.
        View in: PubMed
      289. Curran T, Miller AD, Zokas L, Verma I. Viral and cellular fos proteins: a comparative analysis. Cell. 1984 Feb; 36(2):259-68. PMID: 6319013.
        View in: PubMed
      290. Miller AD, Curran T, Verma I. c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell. 1984 Jan; 36(1):51-60. PMID: 6607118.
        View in: PubMed
      291. Miller AD, Jolly DJ, Friedmann T, Verma I. A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT. Proc Natl Acad Sci U S A. 1983 Aug; 80(15):4709-13. PMID: 6308645; PMCID: PMC384113.
      292. Müller R, Tremblay JM, Adamson ED, Verma I. Tissue and cell type-specific expression of two human c-onc genes. Nature. 1983 Aug 4-10; 304(5925):454-6. PMID: 6877368.
        View in: PubMed
      293. Van Beveren C, van Straaten F, Curran T, Müller R, Verma I. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell. 1983 Apr; 32(4):1241-55. PMID: 6301687.
        View in: PubMed
      294. Jolly DJ, Esty AC, Subramani S, Friedmann T, Verma I. Elements in the long terminal repeat of murine retroviruses enhance stable transformation by thymidine kinase gene. Nucleic Acids Res. 1983 Mar 25; 11(6):1855-72. PMID: 6300781; PMCID: PMC325840.
      295. Curran T, Peters G, Van Beveren C, Teich NM, Verma I. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J Virol. 1982 Nov; 44(2):674-82. PMID: 6292525; PMCID: PMC256311.
      296. Papkoff J, Verma I, Hunter T. Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus. Cell. 1982 Jun; 29(2):417-26. PMID: 6288258.
        View in: PubMed
      297. Doehmer J, Barinaga M, Vale W, Rosenfeld MG, Verma I, Evans RM. Introduction of rat growth hormone gene into mouse fibroblasts via a retroviral DNA vector: expression and regulation. Proc Natl Acad Sci U S A. 1982 Apr; 79(7):2268-72. PMID: 6285377; PMCID: PMC346173.
      298. Papkoff J, Lai MH, Hunter T, Verma I. Analysis of transforming gene products from Moloney murine sarcoma virus. Cell. 1981 Nov; 27(1 Pt 2):109-19. PMID: 6276018.
        View in: PubMed
      299. Van Beveren C, van Straaten F, Galleshaw JA, Verma I. Nucleotide sequence of the genome of a murine sarcoma virus. Cell. 1981 Nov; 27(1 Pt 2):97-108. PMID: 6173134.
        View in: PubMed
      300. van der Putten H, Quint W, van Raaij J, Maandag ER, Verma I, Berns A. M-MuLV-induced leukemogenesis: integration and structure of recombinant proviruses in tumors. Cell. 1981 Jun; 24(3):729-39. PMID: 7249080.
        View in: PubMed
      301. Sutcliffe JG, Shinnick TM, Verma I, Lerner RA. Nucleotide sequence of Moloney leukemia virus: 3' end reveals details of replications, analogy to bacterial transposons, and an unexpected gene. Proc Natl Acad Sci U S A. 1980 Jun; 77(6):3302-6. PMID: 6251454; PMCID: PMC349603.
      302. Van Beveren C, Goddard JG, Berns A, Verma I. Structure of Moloney murine leukemia viral DNA: nucleotide sequence of the 5' long terminal repeat and adjacent cellular sequences. Proc Natl Acad Sci U S A. 1980 Jun; 77(6):3307-11. PMID: 6251455; PMCID: PMC349604.
      303. Sutcliffe JG, Shinnick TM, Lerner RA, Johnson P, Verma I. Nucleotide sequence of a cloned murine leukemia virus DNA fragment. Cold Spring Harb Symp Quant Biol. 1980; 44 Pt 2,:1275-9. PMID: 6159135.
        View in: PubMed
      Inder's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _